Debarati Bhanja

7PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsNanomedicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
A phase 0 clinical trial to evaluate the neuropharmacological profile of posaconazole for glioblastoma.

|Jun 02, 2025
A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy.

Debarati Bhanja, Junjia Zhu, Hannah Wilding

|Apr 12, 2024
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.

Nicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja

|Jul 14, 2023
Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability.

Debarati Bhanja, Hannah Wilding, Angel Baroz

|Jul 21, 2022
Neuropharmacological Study of Posaconazole for Glioblastoma: A Phase 0 Clinical Trial Protocol.

Debarati Bhanja, Jeffrey Neighbors, James Connor

|Mar 25, 2022
Association of Low-Grade Glioma Diagnosis and Management Approach with Mental Health Disorders: A MarketScan Analysis 2005-2014.

Debarati Bhanja, Djibril Ba, Kyle Tuohy

Pageof 2

Frequent Collaborators

3 joint publications

Alireza Mansouri

2 joint publications

Kyle Tuohy

2 joint publications

Leonardo de Macedo Filho

2 joint publications

Manmeet S Ahluwalia